Comparison of Psychotherapy Programs to Treat Panic Disorder

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Completed
CT.gov ID
NCT00353470
Collaborator
National Institute of Mental Health (NIMH) (NIH)
201
2
3
72
100.5
1.4

Study Details

Study Description

Brief Summary

This study will determine the relative effectiveness of three psychotherapies in treating people with a panic disorder.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavioral therapy
  • Behavioral: Applied relaxation training (ART)
  • Behavioral: Panic focused psychodynamic psychotherapy (PFPP)
Phase 3

Detailed Description

Panic disorder (PD) is a debilitating anxiety disorder. It is characterized by unexpected and repeated episodes of intense fear, accompanied by serious physical symptoms, such as chest pain, heart palpitations, shortness of breath, dizziness, or abdominal stress. Available treatments for PD include medication therapy and cognitive behavioral therapy (CBT), a type of psychotherapy that teaches people how to view panic attacks differently and how to reduce anxiety. Approximately 30% of patients refuse medication, however, and nearly 50% do not achieve remission with CBT alone. Therefore, there is a pressing need for additional non-pharmacologic treatment methods. Panic-focused psychodynamic psychotherapy (PFPP) and applied relaxation training (ART) are among some of the other available treatments for PD. During ART, individuals are taught to relax their muscles while being exposed to increasingly frightening situations. PFPP combines elements of CBT with other, more extensive approaches aimed at determining the anxiety's origin and at finding ways to reduce it. This study will compare the effectiveness of PFPP, CBT, and ART in treating PD.

Participants in this single blind study will be randomly assigned to receive PFPP, CBT, or ART for 12 weeks. All participants will attend between 19 and 24 treatment sessions over the course of the study. Upon completing the study, participants will attend monthly follow-up visits for an additional 12 months. Participants assigned to ART who have not responded by the end of treatment may opt to receive PFPP or CBT. Outcomes will be assessed using a variety of scales to determine depression and anxiety symptoms.

Study Design

Study Type:
Interventional
Actual Enrollment :
201 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Dynamic Treatment vs. CBT for Panic Disorder
Study Start Date :
Sep 1, 2006
Actual Primary Completion Date :
Mar 1, 2012
Actual Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Participants will receive panic focused psychodynamic psychotherapy for 12 weeks

Behavioral: Panic focused psychodynamic psychotherapy (PFPP)
PFPP will include 19 to 24 sessions over 12 weeks.

Active Comparator: 2

Participants will receive cognitive behavioral therapy-panic control treatment for 12 weeks

Behavioral: Cognitive behavioral therapy
CBT for panic disorder will include 19 to 24 sessions over 12 weeks.
Other Names:
  • Panic control treatment
  • Active Comparator: 3

    Participants will receive applied relaxation training for 12 weeks

    Behavioral: Applied relaxation training (ART)
    ART with exposure protocol will include 19 to 24 sessions over 12 weeks.
    Other Names:
  • ART
  • Outcome Measures

    Primary Outcome Measures

    1. Panic Disorder Severity Scale [Measured at Month 12 post-treatment]

    Secondary Outcome Measures

    1. Sheehan Disability Scale [Measured at Month 12 post-treatment]

    2. Clinical Global Impressions Scale [Measured at Month 12 post-treatment]

    3. Hamilton Depression Rating Scale [Measured at Month 12 post-treatment]

    4. Hamilton Anxiety Rating Scale [Measured at Month 12 post-treatment]

    5. Anxiety Disorder Sensitivity Index [Measured at Month 12 post-treatment]

    6. Brief Body Sensitivity Interpretation Questionnaire [Measured at Month 12 post-treatment]

    7. Panic-Specific Reflective Function [Measured at Month 12 post-treatment]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Meets DSM-IV diagnosis criteria for primary PD with or without agoraphobia

    • History of at least one spontaneous panic attack per week within the month prior to study entry

    Exclusion Criteria:
    • Active substance dependence within 6 months prior to study entry

    • Lifetime history of any psychotic disorder, including bipolar disorder

    • Acutely suicidal

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Weill Medical College of Cornell University New York New York United States 10065
    2 University of Pennsylvania School of Medicine Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • Weill Medical College of Cornell University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Barbara Milrod, MD, Weill Medical College of Cornell University
    • Principal Investigator: Jacques P. Barber, PhD, University of Pennsylvania

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Barbara Milrod, Professor of Psychiatry, Weill Medical College of Cornell University
    ClinicalTrials.gov Identifier:
    NCT00353470
    Other Study ID Numbers:
    • R01MH070918
    • R01MH070664
    First Posted:
    Jul 18, 2006
    Last Update Posted:
    May 3, 2018
    Last Verified:
    Apr 1, 2018
    Keywords provided by Barbara Milrod, Professor of Psychiatry, Weill Medical College of Cornell University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2018